医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

International Bonded Couriers to Manage Cryoport’s Asian Operations

2012年11月14日 PM10:25
このエントリーをはてなブックマークに追加


 

LAKE FOREST, Calif.

CryoPort, Inc. (OTCBB: CYRX) announced that International Bonded Couriers, Inc., (IBC) has agreed to manage an operations center in Singapore for warehousing, shipping and receiving in support of Cryoport’s Asian operations. IBC maintains more than 50 offices worldwide, uniting all facets of international delivery and logistics with an advanced, integrated computer network.

“International Bonded Couriers is delighted to enter into this collaboration with Cryoport, a leading cold chain logistics service provider,” said Robert Paterson, IBC’s Chief Commercial Officer. “Our combined services and technologies, plus our turnkey approach to customer satisfaction, offer Cryoport and their sponsor clients a robust and proven option to more effectively meet their clinical development goals.”

Cryoport’s Chief Commercial Officer Steven Leatherman stated, “We are pleased to strengthen our relationship with IBC. With our rapidly growing ‘deep frozen’ customer base, IBC provides Cryoport with a fully flexible and collaborative approach to solving our customer’s logistics demands.”

About International Bonded Couriers, Inc.

International Bonded Couriers, Inc. (IBC) was established in 1979 and provides customized logistic solutions that are designed to ensure 100% customer satisfaction. Many of their clients only look to IBC for all their global transportation and logistics requirements. IBC operates out of three gateways; Miami directs operations into Central America, South America, and the Caribbean, New York operates into Europe, and Los Angeles provides the gateway to the Asia Pacific region. For more information please visit www.ibcinc.com.

About Cryoport, Inc.

Cryoport provides leading edge frozen shipping logistics services through the combination of purpose built proprietary technologies and total turnkey management of the entire process. The Cryoport Express® liquid nitrogen dry vapor shipper is validated to maintain a constant -150°C temperature for a 10 plus day dynamic shipment duration, and its Cryoportal™ Logistics Management Platform manages the entire shipment process, including initial order, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport’s total turnkey service management approach offers reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a “green” and environmentally friendly solution. For more information visit www.cryoport.com.

Forward Looking Statements

Statements in this press release which are not purely historical, including statements regarding Cryoport, Inc.’s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company’s actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company’s cash flow, market acceptance risks, and technical development risks. The company’s business could be affected by a number of other factors, including the risk factors listed from time to time in the company’s SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2012. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Cryoport, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

CONTACT

LHA
Don Markley, 310-691-7100
dmarkley@lhai.com
@LHA_IR_PR

同じカテゴリーの記事 

  • Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft
  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表
  • Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
  • 领先的合同开发和制造组织PCI Pharma Services发布首份综合ESG报告
  • EverEx Secures iF Design Award for “MORA,” a Leading Musculoskeletal Rehabilitation Solution